BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.97B |
| 2 |
Amazon
AMZN
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$345M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$322M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$302M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
+$343M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$308M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$301M |
| 4 |
IAC Inc
IAC
|
+$203M |
| 5 |
Visa
V
|
+$176M |
Sector Composition
| 1 | Technology | 17.42% |
| 2 | Consumer Discretionary | 10.68% |
| 3 | Healthcare | 7.66% |
| 4 | Financials | 7.63% |
| 5 | Communication Services | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFE
2951
DELISTED
Safeguard Scientifics, Inc.
SFE
| $28K | ﹤0.01% |
5,112
+4,298
| +528% | +$23.6K |
|
|
GPX
2952
DELISTED
GP Strategies Corp.
GPX
| $27.8K | ﹤0.01% |
2,886
+2,408
| +504% | +$23.2K |
|
2953
Stratus Properties
STRS
$161M
| $27.8K | ﹤0.01% |
1,288
+995
| +340% | +$21.5K |
|
|
FLNT
2954
Fluent
FLNT
$49.3M
| $27.8K | ﹤0.01% |
1,865
+1,280
| +219% | +$19K |
|
2955
Immersion
IMMR
$221M
| $27.7K | ﹤0.01% |
3,928
+2,779
| +242% | +$19.6K |
|
2956
Northeast Bank
NBN
$946M
| $27.6K | ﹤0.01% |
1,499
+1,275
| +569% | +$23.5K |
|
|
INDT
2957
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $27.6K | ﹤0.01% |
516
+443
| +607% | +$23.7K |
|
|
UBX
2958
DELISTED
Unity Biotechnology
UBX
| $27.4K | ﹤0.01% |
793
+672
| +555% | +$23.2K |
|
|
EXTN
2959
DELISTED
Exterran Corporation
EXTN
| $27.4K | ﹤0.01% |
6,591
+5,067
| +332% | +$21.1K |
|
2960
BCB Bancorp
BCBP
$152M
| $27.4K | ﹤0.01% |
3,424
+2,555
| +294% | +$20.4K |
|
2961
Talphera
TLPH
$20.4M
| $27.3K | ﹤0.01% |
961
+748
| +351% | +$21.2K |
|
2962
ProShares Ultra Utilities
UPW
$13.4M
| $27.2K | ﹤0.01% |
542
+374
| +223% | +$18.8K |
|
|
PTVCB
2963
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $27.2K | ﹤0.01% |
2,068
+1,730
| +512% | +$22.7K |
|
|
AGTC
2964
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $27.1K | ﹤0.01% |
5,582
+4,705
| +536% | +$22.9K |
|
2965
Silvercrest Asset Management
SAMG
$138M
| $27.1K | ﹤0.01% |
2,592
+1,519
| +142% | +$15.9K |
|
2966
Hawthorn Bancshares
HWBK
$225M
| $27.1K | ﹤0.01% |
1,609
+1,268
| +372% | +$21.3K |
|
2967
BayCom
BCML
$330M
| $27K | ﹤0.01% |
2,626
+2,190
| +502% | +$22.6K |
|
2968
Genco Shipping & Trading
GNK
$763M
| $26.9K | ﹤0.01% |
3,897
+3,036
| +353% | +$20.9K |
|
2969
BioSig Technologies, Inc. Common Stock
BSGM
$215M
| $26.8K | ﹤0.01% |
543
+438
| +417% | +$21.6K |
|
|
ESSA
2970
DELISTED
ESSA Bancorp
ESSA
| $26.6K | ﹤0.01% |
2,160
+1,858
| +615% | +$22.9K |
|
2971
Intellicheck
IDN
$110M
| $26.5K | ﹤0.01% |
3,977
+3,381
| +567% | +$22.6K |
|
2972
Harvard Bioscience
HBIO
$19.7M
| $26.3K | ﹤0.01% |
8,743
+7,330
| +519% | +$22.1K |
|
|
RESN
2973
DELISTED
Resonant Inc.
RESN
| $26.3K | ﹤0.01% |
11,056
+9,200
| +496% | +$21.9K |
|
|
BOCH
2974
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $26.3K | ﹤0.01% |
3,771
+2,733
| +263% | +$19K |
|
|
CBIO
2975
Crescent Biopharma, Inc. Common Stock
CBIO
$174M
| $26.3K | ﹤0.01% |
86
+68
| +378% | +$20.8K |
|